CY2025 Q2
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| Ernexa Therapeutics Inc. | $190,000.00 | 2025-06-27 | View |
| Femasys Inc. | $4,510,001.00 | 2025-06-30 | View |
| Qualigen Therapeutics, Inc. | $4,258,000.00 | 2025-07-31 | View |
| Hudson Pacific Properties, Inc. | $689,300,000.00 | 2025-06-13 | View |
| PetVivo Holdings, Inc. | $140,000.00 | 2025-06-30 | View |
| ADIAL PHARMACEUTICALS, INC. | $600,000.00 | 2025-06-18 | View |
| AUDDIA INC. | $1,900,000.00 | 2025-08-08 | View |
| Runway Growth Finance Corp. | $200,000.00 | 2025-08-07 | View |
| bioAffinity Technologies, Inc. | $5,800,000.00 | 2025-05-22 | View |
| EQUILLIUM, INC. | $30,000,000.00 | 2025-08-12 | View |
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | $3,900,000.00 | 2025-06-30 | View |
| CISO GLOBAL, INC. | $100,000,000.00 | 2025-06-26 | View |
| ProCap Acquisition Corp | $250,000,000.00 | 2025-05-22 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations